Jiezhong Chen1, Kenneth Raymond. Show Affiliations » 1. School of Pharmacy and Applied Science, Faculty of Science, Technology and Engineering, La Trobe University, Bendigo, Vic 3550, Australia.
Abstract
Entities: Chemical Disease
Mesh： See more » AnimalsBile Acids and Salts/biosynthesisBile Acids and Salts/metabolismChenodeoxycholic Acid/analogs & derivativesChenodeoxycholic Acid/pharmacologyCholestasis/drug therapyCholestasis/etiologyCholestasis/metabolismDNA-Binding Proteins/drug effectsDNA-Binding Proteins/physiologyEnzyme Inhibitors/adverse effectsEnzyme Inhibitors/therapeutic useHomeostasis/drug effectsHumansMicePregnane X ReceptorRatsReceptors, Cytoplasmic and Nuclear/drug effectsReceptors, Cytoplasmic and Nuclear/physiologyReceptors, Steroid/drug effectsReceptors, Steroid/physiologyRifampin/adverse effectsRifampin/therapeutic useTranscription Factors/drug effectsTranscription Factors/physiology
Substances： See more » Bile Acids and SaltsDNA-Binding ProteinsEnzyme InhibitorsPregnane X ReceptorReceptors, Cytoplasmic and NuclearReceptors, SteroidTranscription Factorsobeticholic acidfarnesoid X-activated receptorChenodeoxycholic AcidRifampin
Year: 2006 PMID： 16473109 DOI： 10.1016/S0140-6736(06)68156-7
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321